Medication info

Bajekomdi Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pink, rectangular film-coated tablet
Packaging
28 tablets (28 tablets/PTPx1)
Approval status
Expired

MFDS item code 201902319 · Approved 2019.04.16

This product's status changed to Expired on 2024.04.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Administration is not recommended because the safety and efficacy of this medicine have not been established in patients with hepatic impairment.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • spinal fractures
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the incidence of spinal fractures, helping to maintain bone density and improve bone health. However, its effectiveness in non-spinal fractures has not yet been sufficiently proven, so caution is needed. This medication can reduce the risk of spinal fractures due to osteoporosis and help maintain healthy bones.

How to take

Adult dose

Take 1 tablet once daily, with or without food. If the patient's dietary intake of calcium and vitamin D is insufficient, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: Administration is not recommended because the safety and efficacy of this medicine have not been established in patients with hepatic impairment.

Precautions

This medication may increase the risk of blood clots in the blood. Particularly, conditions such as deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis may occur, so it is not recommended for women with these issues or those at high risk. This medication is only for postmenopausal women and should not be used in premenopausal women, pregnant women, or breastfeeding women. If uterine bleeding occurs during treatment with this medication, professional medical advice should be sought immediately. Additionally, it is not recommended to use this medication for prevention or treatment in breast cancer patients. Individuals with allergies to this medication or its components, a history of thrombosis, unexplained uterine bleeding, symptoms of endometrial cancer, hypercalcemia, or kidney stones should not take this medication. Patients with high triglycerides or poor liver or kidney function, limited mobility, or those taking certain medications should use this medication with caution and under a physician's direction. The use of this medication may lead to side effects such as flushing, leg cramps, drowsiness, dry mouth, hives, rash, thrombosis, etc.; if any unusual symptoms occur, consult a doctor immediately. If there is a high risk of vitamin D deficiency, supplemental vitamin D should be taken, and if calcium intake is insufficient, it is recommended to take calcium supplements concurrently. This medication may cause drowsiness or vision disturbances when driving or operating machinery, so caution is needed. In case of an overdose, since there is no specific antidote, treatment should be symptomatic, especially in cases of vitamin D overdose, where calcium levels should be regularly monitored. This medication should be kept out of reach of children and stored in its original container. Women who are pregnant or may become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be stopped immediately. This medication is not used in children and can be used in the elderly without special dose adjustments, but liver function changes should be considered.

Side effects

Hypersensitivity, drowsiness, retinal vein thrombosis, flushing, deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, elevated serum triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased vision, blurred vision, photopsia, visual field deficit, visual impairment, dry eye syndrome, eyelid swelling, eyelid spasm, eye pain, ocular edema, abdominal pain, death, fever, generalized edema, fatigue, fractures, muscle pain, rotator cuff syndrome, spinal canal stenosis, cerebral infarction, cerebral hemorrhage, bradycardia, respiratory failure, vomiting, gastritis, colon polyps, belching, allergic reaction, chest discomfort, leg pain, edema, facial swelling, changes in temperature sensation, lethargy, weakness, lack of efficacy, dermatitis, localized skin reaction, increased sweating, eczema, hair loss, low back pain, joint pain, muscle weakness, headache, pharyngitis, pyelonephritis, palpitations, sputum disorder, cough, asthma, dyspnea, laryngitis, increased alkaline phosphatase, liver cyst, hepatocyte damage, biliary stones, weight gain, hyperlipidemia, central obesity, dysuria, urinary abnormalities, renal cyst, urinary incontinence, vaginal bleeding, breast congestion, insomnia, leukocytosis, laceration, contusion, psychological symptoms, altered consciousness, headache, nausea, vomiting, loss of appetite, weight loss, increased thirst, arrhythmia, increased urinary frequency, kidney stones, renal calcification, calcification in the outer tissue of the bone, muscle pain, joint pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture. The appropriate storage temperature is room temperature between 1 degree and 30 degrees. Avoid storing it in excessively hot or cold places.

Appearance and packaging

Appearance

Pink, rectangular film-coated tablet

Package unit

28 tablets (28 tablets/PTPx1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.